发明名称 |
USE OF 2-(3,4-DIMETHOXYCINNAMOYL)AMINOBENZOIC ACID FOR THE TREATMENT OF RESTENOSIS ASSOCIATED WITH CORONARY INTERVENTION |
摘要 |
This invention provides a pharmaceutical composition for the treatment or prevention of restenosis associated with coronary intervention, containing, as an active ingredient, 2-(3,4-dimethyoxycinnamoyl)aminobenzoic acid or a pharmaceutically acceptable salt thereof and the use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid or a pharmaceutically acceptable salt thereof for the manufacture of a pharmaceutical for the treatment or prevention of restenosis associated with coronary intervention. A 600 mg dosage of 2-(3,4-dimethoxy-cinnamoyl)aminobenzoic acid for a treatment period of three consecutive months after coronary intervention lowers the incidence of restenosis, and reduces the degree of stenosis in patients.
|
申请公布号 |
CA2106172(C) |
申请公布日期 |
2001.01.02 |
申请号 |
CA19932106172 |
申请日期 |
1993.09.14 |
申请人 |
|
发明人 |
TAMAI, HIDEO;UEDA, KINZO;HSU, YUNG-SHENG |
分类号 |
A61K31/19;A61K31/195;A61P9/00;A61P9/10;A61P43/00;(IPC1-7):A61K31/195 |
主分类号 |
A61K31/19 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|